This document discusses the classification and characteristics of mature lymphoid neoplasms. It covers several types of B-cell and T-cell/NK-cell neoplasms as well as Hodgkin's lymphoma. Chronic lymphocytic leukemia is described in more detail, including that it involves the accumulation of B lymphocytes in the blood, bone marrow, lymph nodes and spleen. Diagnosis involves blood tests and bone marrow aspiration showing lymphocytic dominance. Hodgkin's lymphoma is characterized by the presence of Reed-Sternberg cells in lymph node biopsies and generally has a high survival rate when detected early.
2. Classification of mature Lymphoid Neoplasms
A. B cell Neoplasms e.g.;
• Chronic lymphocytic leukaemia /small lymphocytic
lymphoma
• Plasma cell myeloma
• Hairy cell leukaemia
• Lymphoplasmacytic lymphoma
• Marginal zone lymphoma
• Follicular lymphoma
• Mantle cell lymphoma
• Diffuse large B-cell lymphoma
• Burkitt lymphoma
3. Classification of mature Lymphoid Neoplasms
A. B. Mature T-cell and NK-cell Neoplasms
e.g.;
• T-cell prolymphocytic leukaemia
• T-cell large granular lymphocytic leukaemia
• Aggressive NK-cell leukaemia
• Adult T-cell leukaemia/lymphoma
• Extranodal NK/T-cell lymphoma, nasal type
• Mycosis fungoides Sézary syndrome
4. Classification of mature Lymphoid Neoplasms
A. B. Mature T-cell and NK-cell Neoplasms •
T-cell prolymphocytic leukaemia
• T-cell large granular lymphocytic leukaemia
• Aggressive NK-cell leukaemia
• Adult T-cell leukaemia/lymphoma
• Extranodal NK/T-cell lymphoma, nasal type
• Mycosis fungoides Sézary syndrome
C. Hodgkin Lymphomas
• Nodular lymphocyte predominant Hodgkin
lymphoma
• Classic Hodgkin lymphoma
5. Lymphoma versus Leukaemia
The distinction between lymphoma and lymphoid
leukaemia is often confusing , but as a general rule , a
neoplasm of lymphocytes or lymphocyte precursors that
manifests primarily as a tumor of lymph nodes or related
organs (e.g spleen , liver , or other solid tissues) is
considered as lymphoma ,
while a neoplasm of lymphocytes or lymphocyte
precursors that manifest primarily as a proliferation of
abnormal cells in the blood and bone marrow is
considered as lymphoid leukaemia .
6. Chronic Lymphocytic Leukaemia (CLL)
CLL is a B-cell clonal lymphoproliferative disease in
which lymphocytes accumulate in the blood, bone
marrow, lymph nodes and spleen (absolute clonal B
lymphocyte count >5.0 × 109/L).
CLL has a peak incidence between 60 and 80 years of age.
The disease occurs in older subjects with only 15% of cases
before 50 years of age. The male to female ratio is 2:1.
The cause is unknown.
The most common chromosome changes are trisomy 12,
a 13q deletion and deletions of 11q including the
ataxia telangiectasia (ATM) gene.
7. Clinical features of CLL
Most patients are diagnosed without symptoms as the
result of a routine blood test.
CLL patients present with enlargements of lymph nodes
, which are discrete , and non-tender.
Features of anaemia and thrombocytopenia (bruising
or purpura) may be seen.
Splenomegaly and , less commonly hepatomegaly are
common in later stages.
Immunosupression due to hypogammaglobulinaemia
and cellular immune dysfunction results in bacterial ,
fungal and viral infections.
9. Diagnosis of CLL
- Blood films show lymphocytosis (70-90%) of white blood
cells appear as small lymphocytes. Total leukocyte count
ranges between 30-300x109/L.
- Anemia and thrombocytopenia may be also seen.
- The immunophenotyping of the lymphocytes shows them to
be B cells , which express surface markers CD5+ and CD23+ .
- Bone marrow aspiration shows lymphocytic replacement of
normal marrow elements. lymphocytes comprise about 25-
95% of all the cells.
- Auto immune hemolytic anemia is most frequent in CLL.
10. HODGKIN'S LYMPHOMA
Also known as Hodgkin's disease is a type of lymphoma
first described by Thomas Hodgkin in 1832.
It is characterized clinically by the orderly spread of disease
from one lymph node group to another and by
development of systemic symptoms with advanced disease.
Pathologically , the disease is characterized by the presence
of Reed-Sternberg cells (RS cells) on examination of
affected lymph node biopsies or aspiration.
The survival rate is generally around 90% when the disease
is detected early , making it one of the more curable forms
of cancer.